Multiple ascending dose study of MEDI1341 in participants with Parkinson's Disease

Trial Identifier: D6340C00002
Sponsor: AstraZeneca
Takeda Pharmaceutical Company Ltd
NCTID:: NCT04449484
Start Date: August 2020
Primary Completion Date: January 2022
Study Completion Date: January 2022
Condition: Neurological & Brain - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Spanish (US) Translation

Trial Locations

Country Location
US, CA Long Beach, CA, US, 90806
US, FL Hallandale Beach, FL, US, 33009
US, GA Atlanta, GA, US, 30331
US, IL Chicago, IL, US, 60612
US, MI Farmington Hills, MI, US, 48334
US, OR Portland, OR, US, 97239
US, TX Houston, TX, US, 77058
US, WA Spokane, WA, US, 99202